HTA for pharmaceuticals in Europe : will the mountain deliver a mouse?
Year of publication: |
2020
|
---|---|
Authors: | Garattini, Livio ; Padula, Anna |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 21.2020, 1, p. 1-5
|
Subject: | EU-Staaten | EU countries | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Europa | Europe |
-
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan, (2014)
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Bayerlein, Michael, (2023)
- More ...
-
Defensive medicine in Europe : a "full circle"?
Garattini, Livio, (2020)
-
Pricing vaccines and drugs in Europe : worth differentiating?
Garattini, Livio, (2021)
-
To model or not to model : lessons from two vaccinations
Garattini, Livio, (2011)
- More ...